Investigation Into the Equine Metabolism of Phosphodiesterase‐4 Inhibitor Roflumilast for Potential Doping Control
This paper describes the metabolic transformation of the phosphodiesterase-4 inhibitor Roflumilast in thoroughbred horses after oral intake. Additionally, it presents…